Know Cancer

or
forgot password

Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg


N/A
N/A
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg


Inclusion Criteria:



- Prostate cancer patients who have no history of receiving endocrine therapy
(including surgical castration), and who plan to undergo Casodex® tablets monotherapy
for not less than 12 months

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Adverse event incidence

Outcome Time Frame:

Time since starting Casodex monotherapy, monthly

Safety Issue:

Yes

Authority:

Japan: Institutional Review Board

Study ID:

NIS-OJP-CAS-2009/1

NCT ID:

NCT00919477

Start Date:

May 2009

Completion Date:

March 2012

Related Keywords:

  • Prostate Cancer
  • Prostate cancer
  • Casodex
  • Monotherapy
  • Prostatic Neoplasms

Name

Location